Soon, the Economic Partnership Agreement (EPA) between Japan and the EU will come into force. Along with an already signed Memorandum of Cooperation in Health by the Japanese and Danish Ministers of Health, followed by the fruitful Royal visit to Japan in 2017, there is a unique opportunity for Danish companies to explore and exploit trade and cooperation within the Japanese Health sector.
Therefore, Confederation of Danish Industry and the Royal Danish Embassy in Japan are organizing an exciting program in Tokyo and Osaka for Danish companies within the healthcare industry to gain knowledge of and build trade relations to the Japanese health sector.
Japan has become the second largest market for pharmaceuticals, taking up 11,7 per cent of the global market and imports exceed DKK 5,000 million. The new trade agreement provides great opportunities for Danish companies who wishes to enter the Japanese market.
The delegation program will be tailored to the participating companies and their ambitions and challenges in the Japanese market. Because of the agreement between Japan and Denmark, the Danish embassy in Japan has improved access to Japanese healthcare authorities. By participating in this program you will get unique access to the Japanese healthcare market, meetings with government stakeholders, B2B with Japanese healthcare companies, and visits to hospitals and nursing homes.
The delegation visit is relevant for Danish healthcare companies working within the field of welfare technologies, telemedicine, doctor-to-doctor and doctor-to-patient technologies.
If you are in doubt about your company’s fit to this program or industry, please contact Nina Milling Riiser, Confederation of Danish Industry at (+45) 3377 3672.
Read more about the delegation visit here.
Registration deadline is April 1, 2019.